New R01 Awarded to DC CFAR Investigator Dr. Amanda Castel

amanda and karen
August 07, 2020
Join us in congratulating Dr. Amanda Castel (GW) who was awarded an R01 from the National Institute of Mental Health (NIMH) at the National Institutes of Health (NIH) entitled "Pragmatic Efficacy Trial of mHealth To Improve HIV Outcomes in the DC Cohort". Dr. Castel is the PI of the DC Cohort, a longitudinal cohort of over 10,000 people living with HIV receiving care at fifteen HIV clinics across the District and aims to monitor and improve the quality of HIV care. She also serves as the Director of the DC CFAR Ending the HIV Epidemic Scientific Working Group.
This R01 represents a significant milestone for the DC Cohort as it is the first intervention-based research study to utilize the DC Cohort platform. The project seeks to evaluate the efficacy of PositiveLinks, a theory-based mHealth intervention designed by researchers at the University of Virginia including MPI Dr. Karen Ingersoll (UVA), to increase retention in care and viral suppression among persons living with HIV (PLWH). A cluster randomized trial will be conducted at 14 DC Cohort sites followed by an implementation science evaluation to identify multi-level factors that characterize best practices in program implementation. The study results will inform the development of "a novel and efficacious approach to improving retention in care and viral suppression among PLWH that could contribute to HIV epidemic control."
Click here to read the full proposal.